|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wender R, Fontham ET, Barrera E Jr,
Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle
GS, Kelsey DK, et al: American Cancer Society lung cancer screening
guidelines. CA Cancer J Clin. 63:107–117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sandoval J, Peiró-Chova L, Pallardó FV and
García-Giménez JL: Epigenetic biomarkers in laboratory diagnostics:
Emerging approaches and opportunities. Expert Rev Mol Diagn.
13:457–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim Y and Kim D-H: CpG island
hypermethylation as a biomarker for the early detection of lung
cancer. Cancer Epigenetics. Humana Press. (NY, USA). 141–171. 2015.
View Article : Google Scholar
|
|
8
|
Leygo C, Williams M, Jin HC, Chan MWY, Chu
WK, Grusch M and Cheng YY: DNA methylation as a noninvasive
epigenetic biomarker for the detection of cancer. Dis Markers.
2017:37265952017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Navarro E, Serrano-Heras G, Castaño MJ and
Solera J: Real-time PCR detection chemistry. Clin Chim Acta.
439:231–250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hulbert A, Jusue-Torres I, Stark A, Chen
C, Rodgers K, Lee B, Griffin C, Yang A, Huang P, Wrangle J, et al:
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation
in Plasma and Sputum. Clin Cancer Res. 23:1998–2005. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brait M, Ling S, Nagpal JK, Chang X, Park
HL, Lee J, Okamura J, Yamashita K, Sidransky D and Kim MS: Cysteine
dioxygenase 1 is a tumor suppressor gene silenced by promoter
methylation in multiple human cancers. PLoS One. 7:e449512012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Minatani N, Waraya M, Yamashita K, Kikuchi
M, Ushiku H, Kojo K, Ema A, Nishimiya H, Kosaka Y, Katoh H, et al:
Prognostic significance of promoter DNA hypermethylation of
cysteine dioxygenase 1 (CDO1) gene in primary breast cancer. PLoS
One. 11:e01448622016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi JI, Cho E-H, Kim SB, Kim R, Kwon J,
Park M, Shin HJ, Ryu HS, Park SH and Lee KH: Promoter methylation
of cysteine dioxygenase type 1: Gene silencing and tumorigenesis in
hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg.
21:181–187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Igarashi K, Yamashita K, Katoh H, Kojima
K, Ooizumi Y, Nishizawa N, Nishiyama R, Kawamata H, Tajima H, Kaizu
T, et al: Prognostic significance of promoter DNA hypermethylation
of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder
cancer and gallbladder disease. PLoS One. 12:e01881782017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vedeld HM, Andresen K, Eilertsen IA,
Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO,
Boberg KM and Lind GE: The novel colorectal cancer biomarkers CDO1,
ZSCAN18 and ZNF331 are frequently methylated across
gastrointestinal cancers. Int J Cancer. 136:844–853. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meller S, Zipfel L, Gevensleben H,
Dietrich J, Ellinger J, Majores M, Stein J, Sailer V, Jung M,
Kristiansen G, et al: CDO1 promoter methylation is associated with
gene silencing and is a prognostic biomarker for biochemical
recurrence-free survival in prostate cancer patients. Epigenetics.
11:871–880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwon J, Park M, Kim JH, Lee HW, Kang MC
and Park JH: Epigenetic regulation of the novel tumor suppressor
cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Tumour Biol. 36:7449–7456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng N, Wang Y, Zheng M, Yu X, Lin H, Ma
RN, Shi O, Zheng X, Gao M, Yu H, et al: Genome-wide analysis of DNA
methylation and their associations with long noncoding RNA/mRNA
expression in non-small-cell lung cancer. Epigenomics. 9:137–153.
2017. View Article : Google Scholar
|
|
20
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al; International Association for the
Study of Lung Cancer Staging and Prognostic Factors Committee,
Advisory Boards, Participating Institutions; International
Association for the Study of Lung Cancer Staging and Prognostic
Factors Committee Advisory Boards and Participating Institutions, .
The IASLC Lung Cancer Staging Project: Proposals for Revision of
the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the
TNM Classification for Lung Cancer. J Thorac Oncol. 11:39–51. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kwon YJ, Lee SJ, Koh JS, Kim SH, Lee HW,
Kang MC, Bae JB, Kim YJ and Park JH: Genome-wide analysis of DNA
methylation and the gene expression change in lung cancer. J Thorac
Oncol. 7:20–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wrangle J, Machida EO, Danilova L, Hulbert
A, Franco N, Zhang W, Glöckner SC, Tessema M, Van Neste L, Easwaran
H, et al: Functional identification of cancer-specific methylation
of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin
Cancer Res. 20:1856–1864. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ooki A, Maleki Z, Tsay JJ, Goparaju C,
Brait M, Turaga N, Nam HS, Rom WN, Pass HI, Sidransky D, et al: A
Panel of Novel Detection and Prognostic Methylated DNA Markers in
Primary Non-Small Cell Lung Cancer and Serum DNA. Clin Cancer Res.
23:7141–7152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Diaz-Lagares A, Mendez-Gonzalez J, Hervas
D, Saigi M, Pajares MJ, Garcia D, Crujerias AB, Pio R, Montuenga
LM, Zulueta J, et al: A Novel Epigenetic Signature for Early
Diagnosis in Lung Cancer. Clin Cancer Res. 22:3361–3371. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brait M, Ling S, Nagpal JK, Chang X, Park
HL, Lee J, Okamura J, Yamashita K, Sidransky D and Kim MS: Cysteine
dioxygenase 1 is a tumor suppressor gene silenced by promoter
methylation in multiple human cancers. PLoS One. 7:e449512012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramalho-Carvalho J, Henrique R and
Jerónimo C: Methylation-specific PCR. DNA Methylation Protocols.
1708. Tost J: Springer, Humana Press; New York, NY: pp. 447–472.
2018, View Article : Google Scholar
|
|
27
|
Holmes EE, Jung M, Meller S, Leisse A,
Sailer V, Zech J, Mengdehl M, Garbe LA, Uhl B, Kristiansen G, et
al: Performance evaluation of kits for bisulfite-conversion of DNA
from tissues, cell lines, FFPE tissues, aspirates, lavages,
effusions, plasma, serum, and urine. PLoS One. 9:e939332014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
López-Otín C, Blasco MA, Partridge L,
Serrano M and Kroemer G: The hallmarks of aging. Cell.
153:1194–1217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Derhovanessian E, Solana R, Larbi A and
Pawelec G: Immunity, ageing and cancer. Immun Ageing. 5:112008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rodier F and Campisi J: Four faces of
cellular senescence. J Cell Biol. 192:547–556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bakulski KM and Fallin MDJE: Epigenetic
epidemiology: Promises for public health research. Environ Mol
Mutagen. 55:171–183. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Levine ME, Hosgood HD, Chen B, Absher D,
Assimes T and Horvath S: DNA methylation age of blood predicts
future onset of lung cancer in the women's health initiative. Aging
(Albany NY). 7:690–700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Breitling LP, Yang R, Korn B, Burwinkel B
and Brenner H: Tobacco-smoking-related differential DNA
methylation: 27K discovery and replication. Am J Hum Genet.
88:450–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
